| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (groß) | News | Bilanz/GuV | Dividende/HV | Zertifikate | Depot |
| Times + Sales | Chart-Analyse | Analysen | Schätzungen | Termine | Optionsscheine | Watchlist |
| Börsenplätze | Chartvergleich | Kursziele | Profil | Knock-Outs | myHome | |
| Orderbuch | Realtime Stuttgart | Insidertrades | Fonds | Senden/Drucken | ||
| Historisch | Realtime Push | myNews | im Forum | Anleihen | ||
Elan zu myNews hinzufügen Was ist das?
Elan Corporation, plc (NYSE: ELN) announced today that it will present at the Deutsche Bank 37th Annual Healthcare Conference on Tuesday, May 8, 2012 at 10.40 a.m. Eastern Standard Time, 3:40pm Greenwich Mean Time.
Interested parties may access a live audio webcast of the presentation by visiting the Investor Relations section of the Elan website at http://www.elan.com, then clicking on the event icon. Following the live webcast, an archived version of the presentation will be available at the same URL.
About Elan
Elan is a neuroscience focused biotechnology company committed to making a difference in the lives of patients and their families by dedicating itself to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world. For additional information about Elan, please visit http://www.elan.com.
| Geben Sie jetzt einen Kommentar zu diesem Artikel ab. |
23.05.13 | Elan Announces Pricing of US$850 Million in Aggregate Principal Amount of Senior Notes Due 2021 (Businesswire) |
23.05.13 | Royalty beißt bei Elan weiter auf Granit: Auch erhöhtes Angebot abgelehnt (dpa-afx) |
23.05.13 | Elan Corporation, plc?s Board of Directors Unanimously Reject Royalty Pharma?s Revised Tender Offer (Businesswire) |
20.05.13 | ROUNDUP/Aktien New York Schluss: Dow etwas leichter nach kurzem Höhenflug (dpa-afx) |
20.05.13 | Aktien New York: Stabil nach kurzzeitig fortgesetzten Höhenflügen (dpa-afx) |
20.05.13 | Royalty beißt sich bei Elan fest: Übernahmeangebot auf 12,50 Dollar erhöht (dpa-afx) |
20.05.13 | Elan?s Response to Royalty Pharma Announcement (Businesswire) |
20.05.13 | Elan Corporation, plc -- Moody's confirms Elan at Ba3 and assigns Ba3 to new sr. notes (Moodys) |
23.05.13 | Elan Announces Pricing of US$850 Million in Aggregate Principal Amount of Senior Notes Due 2021 (Businesswire) |
23.05.13 | Elan Corporation, plc?s Board of Directors Unanimously Reject Royalty Pharma?s Revised Tender Offer (Businesswire) |
20.05.13 | Elan?s Response to Royalty Pharma Announcement (Businesswire) |
20.05.13 | Elan Announces Transactions: Decisively Transforming the Company (Businesswire) |
20.05.13 | Elan Announces Proposed Offering of US$800.0 Million in Aggregate Principal Amount of Senior Notes Due 2021 (Businesswire) |
15.05.13 | Elan Announces Publication of Response Document (Businesswire) |
13.05.13 | Elan Provides Additional Commentary on Elan/Theravance Royalty Participation Agreement (Businesswire) |
13.05.13 | Theravance and Elan Enter Into a $1.0 Billion Royalty Participation Agreement (Businesswire) |
| Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv |
23.05.13 | Elan Announces Pricing of US$850 Million in Aggregate Principal Amount of Senior Notes Due 2021 (Businesswire) |
23.05.13 | Elan Corporation, plc?s Board of Directors Unanimously Reject Royalty Pharma?s Revised Tender Offer (Businesswire) |
20.05.13 | Elan?s Response to Royalty Pharma Announcement (Businesswire) |
20.05.13 | Elan Corporation, plc -- Moody's confirms Elan at Ba3 and assigns Ba3 to new sr. notes (Moodys) |
20.05.13 | Elan Announces Transactions: Decisively Transforming the Company (Businesswire) |
20.05.13 | Elan Announces Proposed Offering of US$800.0 Million in Aggregate Principal Amount of Senior Notes Due 2021 (Businesswire) |
15.05.13 | Elan Announces Publication of Response Document (Businesswire) |
13.05.13 | Elan Corporation, plc -- Moody's reviews Elan's ratings for downgrade (Moodys) |
| Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv |
23.05.13 | Elan Announces Pricing of US$850 Million in Aggregate Principal Amount of Senior Notes Due 2021 (Businesswire) |
23.05.13 | Elan Corporation, plc?s Board of Directors Unanimously Reject Royalty Pharma?s Revised Tender Offer (Businesswire) |
20.05.13 | Elan?s Response to Royalty Pharma Announcement (Businesswire) |
20.05.13 | Elan Announces Transactions: Decisively Transforming the Company (Businesswire) |
20.05.13 | Elan Announces Proposed Offering of US$800.0 Million in Aggregate Principal Amount of Senior Notes Due 2021 (Businesswire) |
15.05.13 | Elan Announces Publication of Response Document (Businesswire) |
13.05.13 | Elan Provides Additional Commentary on Elan/Theravance Royalty Participation Agreement (Businesswire) |
13.05.13 | Theravance and Elan Enter Into a $1.0 Billion Royalty Participation Agreement (Businesswire) |
20.05.13 | Royalty beißt sich bei Elan fest: Übernahmeangebot auf 12,50 Dollar erhöht (dpa-afx) |
23.05.13 | Royalty beißt bei Elan weiter auf Granit: Auch erhöhtes Angebot abgelehnt (dpa-afx) |
20.05.13 | Royalty beißt sich bei Elan fest: Übernahmeangebot auf 12,50 Dollar erhöht (dpa-afx) |
23.05.13 | Royalty beißt bei Elan weiter auf Granit: Auch erhöhtes Angebot abgelehnt (dpa-afx) |
| Keine Nachrichten im Zeitraum eines Monats in dieser Kategorie verfügbar |
23.05.13 | Elan Announces Pricing of US$850 Million in Aggregate Principal Amount of Senior Notes Due 2021 (Businesswire) |
15.05.13 | Elan Announces Publication of Response Document (Businesswire) |
20.05.13 | ROUNDUP/Aktien New York Schluss: Dow etwas leichter nach kurzem Höhenflug (dpa-afx) |
20.05.13 | Aktien New York: Stabil nach kurzzeitig fortgesetzten Höhenflügen (dpa-afx) |
13.05.13 | Aktien New York Ausblick: Moderate Verluste - Pharmabranche weiter im Fokus (dpa-afx) |
13.05.13 | ROUNDUP/Aktien New York Schluss: Dow moderat schwächer nach Rekordjagd (dpa-afx) |
13.05.13 | Aktien New York: Uneinheitlich - Dow Jones moderat im Minus nach Rekordjagd (dpa-afx) |
20.05.13 | Royalty beißt sich bei Elan fest: Übernahmeangebot auf 12,50 Dollar erhöht (dpa-afx) |
23.05.13 | Elan Announces Pricing of US$850 Million in Aggregate Principal Amount of Senior Notes Due 2021 (Businesswire) |
15.05.13 | Elan Announces Publication of Response Document (Businesswire) |
20.05.13 | Elan Announces Transactions: Decisively Transforming the Company (Businesswire) |
20.05.13 | Elan?s Response to Royalty Pharma Announcement (Businesswire) |
25.04.13 | Elan Announces Publication of Notice of 2013 Annual General Meeting & Directors? Retirement (Businesswire) |
23.05.13 | Elan Corporation, plc?s Board of Directors Unanimously Reject Royalty Pharma?s Revised Tender Offer (Businesswire) |
13.05.13 | Elan Provides Additional Commentary on Elan/Theravance Royalty Participation Agreement (Businesswire) |
20.05.13 | Elan Announces Proposed Offering of US$800.0 Million in Aggregate Principal Amount of Senior Notes Due 2021 (Businesswire) |
23.05.13 | Elan Announces Pricing of US$850 Million in Aggregate Principal Amount of Senior Notes Due 2021 (Businesswire) |
15.05.13 | Elan Announces Publication of Response Document (Businesswire) |
20.05.13 | Elan Announces Transactions: Decisively Transforming the Company (Businesswire) |
20.05.13 | Elan?s Response to Royalty Pharma Announcement (Businesswire) |
25.04.13 | Elan Announces Publication of Notice of 2013 Annual General Meeting & Directors? Retirement (Businesswire) |
23.05.13 | Elan Corporation, plc?s Board of Directors Unanimously Reject Royalty Pharma?s Revised Tender Offer (Businesswire) |
13.05.13 | Elan Provides Additional Commentary on Elan/Theravance Royalty Participation Agreement (Businesswire) |
20.05.13 | Elan Announces Proposed Offering of US$800.0 Million in Aggregate Principal Amount of Senior Notes Due 2021 (Businesswire) |
| Keine Nachrichten im Zeitraum eines Monats in dieser Kategorie verfügbar |
23.05.13 | Elan Announces Pricing of US$850 Million in Aggregate Principal Amount of Senior Notes Due 2021 (Businesswire) |
15.05.13 | Elan Announces Publication of Response Document (Businesswire) |
20.05.13 | Elan Announces Transactions: Decisively Transforming the Company (Businesswire) |
20.05.13 | Elan?s Response to Royalty Pharma Announcement (Businesswire) |
25.04.13 | Elan Announces Publication of Notice of 2013 Annual General Meeting & Directors? Retirement (Businesswire) |
23.05.13 | Elan Corporation, plc?s Board of Directors Unanimously Reject Royalty Pharma?s Revised Tender Offer (Businesswire) |
13.05.13 | Elan Provides Additional Commentary on Elan/Theravance Royalty Participation Agreement (Businesswire) |
20.05.13 | Elan Announces Proposed Offering of US$800.0 Million in Aggregate Principal Amount of Senior Notes Due 2021 (Businesswire) |
Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen
Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen
vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden
Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören
Twitter: Tweets mit dem Cashtag des Unternehmens
| 08.08.12 | Elan neutral | Exane-BNP Paribas SA | |
| 02.08.12 | Elan outperform | RBC Capital Markets | |
| 26.07.12 | Elan neutral | Exane-BNP Paribas SA | |
| 26.07.12 | Elan neutral | UBS AG | |
| 23.07.12 | Elan outperform | RBC Capital Markets |
| 02.08.12 | Elan outperform | RBC Capital Markets | |
| 23.07.12 | Elan outperform | RBC Capital Markets | |
| 22.06.12 | Elan outperform | RBC Capital Markets | |
| 14.06.12 | Elan buy | Jefferies & Company Inc. | |
| 28.03.12 | Elan outperform | RBC Capital Markets |
| 08.08.12 | Elan neutral | Exane-BNP Paribas SA | |
| 26.07.12 | Elan neutral | Exane-BNP Paribas SA | |
| 26.07.12 | Elan neutral | UBS AG | |
| 27.04.12 | Elan neutral | Exane-BNP Paribas SA | |
| 13.01.11 | Elan neutral | UBS AG |
| 21.07.10 | Elan reduce | Goodbody Stockbrokers | |
| 16.07.10 | Elan "reduce" | Goodbody Stockbrokers | |
| 02.08.06 | Update Elan Corporation plc (Spons. ADRs): Underpe | Piper Jaffray | |
| 06.06.06 | Update Elan Corporation plc (Spons. ADRs): Underpe | Piper Jaffray | |
| 20.01.06 | Update Elan Corporation plc (Spons. ADRs): Underwe | Lehman Brothers |
Alle: Alle Empfehlungen
Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
| Elan Corporation PLC (spons. ADRs) | 9,54 | 2,79% |
 | DAX: Die Gehälter 2012 Welcher Vorstands- vorsitzende verdiente 2012 am besten? Jetzt durchklicken. |
 | DAX: Das 1. Quartal 2013 Welche Aktien konnten im Auftaktquartal besonders deutlich steigen? Jetzt durchklicken. |
 | Lamborghini Veneno Das teuerste Auto der Welt in Zahlen und Bildern Jetzt durchklicken. |
 | Sport: Die Topverdiener 2012 Welcher Sportler verdiente weltweit am meisten? Jetzt durchklicken. |
 | Rohstoffe 1. Quartal Top und Flop-Commodities Jetzt durchklicken. |
